Form 4: Q32 Bio Inc. Director Laporte Acquires Stock Options
SEC Form 4 Filing
Director Kathleen Laporte acquired stock options for 12,767 shares of Q32 Bio Inc. on March 25, 2024.
Summary
- Kathleen Laporte, a director of Q32 Bio Inc., filed a Form 4 on March 27, 2024, reporting a transaction.
- On March 25, 2024, Laporte acquired stock options for 12,767 shares of Q32 Bio Inc. at an exercise price of $16.82.
- These options vest over time, with one-third vesting on March 25, 2025, and the remainder vesting in 24 equal monthly installments, contingent upon continued service.
- Following the transaction, Laporte directly owns derivative securities for 12,767 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing the acquisition of stock options by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders (directors, officers, and 10% owners) of publicly traded companies, providing transparency into their transactions in the company's securities. This allows investors to monitor insider activity, which can sometimes provide insights into the company's prospects.
Stakeholder Impact
- Shareholders may be interested in this information as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 03/25/2024 | Date of the transaction where Laporte acquired stock options. |
| 03/25/2025 | Date when one-third of the stock options begin to vest. |
| 03/24/2034 | Expiration date of the stock options. |
| 03/27/2024 | Date the Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.